Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2011
08/17/2011EP2356224A1 Methods of inhibiting inflammation-associated tissue damage by inhibiting neutrophil activity
08/17/2011EP2356106A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
08/17/2011EP2355836A2 Compositions and methods for promoting vascular barrier function and treating pulmonary fibrosis
08/17/2011EP2355815A1 Use of leukotriene inhibitors for treating lung diseases in prematurely born infants
08/17/2011EP2355808A2 Arformoterol and tiotropium compositions and methods for use
08/17/2011EP2355807A1 Inhibitors of dimethylarginine dimethylaminohydrolase
08/17/2011EP2355657A1 Compositions and methods of treating endothelial disorders
08/17/2011EP2010490B1 Crystalline forms of a dimethylphenyl compound
08/17/2011EP1819686B1 5-hydroxy-benzothiazole derivatives having beta-2-adrenorecptor agonist activity
08/17/2011EP1687295B1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
08/17/2011EP1558273B1 Treatment and prevention of pulmonary conditions
08/17/2011EP1485360B1 Sodium channel blockers
08/17/2011EP1444233B1 A2b adenosine receptor antagonists
08/17/2011EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
08/17/2011CN201928937U 桑叶除臭脱涩设备 Mulberry deodorant Deastringency equipment
08/17/2011CN1894236B Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/17/2011CN1715926B Use of neuregulin mutant
08/17/2011CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses
08/17/2011CN102159709A New therapeutic agent for malignant mesothelioma and immunostimulant
08/17/2011CN102159582A Oxazolopyrimidines as edg-1 receptor agonists
08/17/2011CN102159573A Pyrazolo pyridine derivatives as nadph oxidase inhibitors
08/17/2011CN102159562A Chromene modulators of chemokine receptor activity
08/17/2011CN102159555A Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases
08/17/2011CN102159531A Cyclohexenyl modulators of chemokine receptor activity
08/17/2011CN102159225A Non-typeable haemophilus influenzae vaccines and their uses
08/17/2011CN102159220A Thiolated chitosan gel
08/17/2011CN102159201A 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
08/17/2011CN102153555A Carbapenem compound containing amido formacyl heterocycle
08/17/2011CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/17/2011CN102153532A Application of eriosema chinense isoflavone compound
08/17/2011CN102153482A Method for refining injection-level ambroxol hydrochloride, product and injection thereof
08/17/2011CN102151322A Chinese medicine composition for treating cold in children, preparation method and detection method thereof
08/17/2011CN102151291A Use of antrodia camphorata for treating diseases
08/17/2011CN102151290A Preparation method of poultry specific transfer factors
08/17/2011CN102151283A Compound medicament for preventing and treating chicken diseases
08/17/2011CN102151278A Use of 2-deoxy-D-glucose in prevention and treatment of viral diseases in livestock
08/17/2011CN102151263A Veterinary compound hydrochloric acid injection and preparation method thereof
08/17/2011CN102151261A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
08/17/2011CN102150850A Debitterized pomelo peel processed powder
08/17/2011CN101884691B Composition of traditional Chinese medicine for treating respiratory diseases of chicken
08/17/2011CN101843860B Chinese medicament for treating children cold
08/17/2011CN101836953B Ambroxol hydrochloride composition injection
08/17/2011CN101829286B Lung moistening and cough relieving pills
08/17/2011CN101732553B Quality inspection method of cough pills
08/17/2011CN101732382B New application of fragrant ainsliaea herb extract
08/17/2011CN101665481B Extraction method of eriosema chinense isoflavoid compound
08/17/2011CN101665480B Extraction method of eriosema chinense isoflavoid extract
08/17/2011CN101647960B Traditional Chinese medicine for treating coughs and asthma
08/17/2011CN101632747B Preparation technology of children cold relaxation grain
08/17/2011CN101537056B Method for preparing Chinese medicinal preparation for treating external respiration infection of children
08/17/2011CN101530493B Medicament combination for curing respiratory diseases and application thereof
08/17/2011CN101491634B Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method and quality control method thereof
08/17/2011CN101455778B Traditional Chinese medicine preparation capable of reducing fever and relieving sore-throat and preparation method thereof
08/17/2011CN101444332B Health care blended type cigarette
08/17/2011CN101439083B Detection method of Chinese medicine soft capsules for clearing wind heat and clearing nasal passage
08/17/2011CN101396544B Traditional Chinese medicine composition capable of ventilating the lung and relieving asthma and preparation method thereof
08/17/2011CN101366850B Rhinitis treating medicament and preparation method
08/17/2011CN101254268B Chinese medicine for curing coryza
08/17/2011CN101244072B Application of asiaticoside in pulmonary fibrosis resistant delayed period
08/17/2011CN101238871B Balloonflower loquat honey tablet
08/16/2011US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto
08/16/2011US7998931 Vascular endothelial cell growth factor antagonists and uses thereof
08/16/2011US7998477 Spherical protein particles and methods for making and using them
08/16/2011CA2624749C Pyrimidine amide compounds as pgds inhibitors
08/16/2011CA2496731C Novel benzonaphthyridines
08/16/2011CA2487095C Elongase genes and uses thereof
08/12/2011DE202010007074U1 Neue Darreichungsformen für Cineol New forms of cineole
08/11/2011WO2011097571A2 Methods for the use of progestogen as a glucocorticoid sensitizer
08/11/2011WO2011097087A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors
08/11/2011WO2011096909A1 Pharmaceutical compositions comprising fluticasone, tiotropium and sodium cromoglycate
08/11/2011WO2011096490A1 Imidazopyridin-2-one derivative
08/11/2011WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
08/11/2011WO2011096377A1 Pyrrole compound
08/11/2011WO2011095534A1 sGC STIMULATORS OR sGC ACTIVATORS ALONE AND IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF CYSTIC FIBROSIS
08/11/2011WO2011095495A1 Compositions and methods for inhibiting expression of ikk2 genes
08/11/2011WO2011041462A3 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/11/2011US20110196128 Murine zcytor17 ligand polynucleotides
08/11/2011US20110196018 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
08/11/2011US20110196016 Compositions and Methods for Inhibiting Expression of IKK2 Genes
08/11/2011US20110195992 New compounds ii
08/11/2011US20110195976 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol
08/11/2011US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists
08/11/2011US20110195973 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
08/11/2011US20110195967 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
08/11/2011US20110195965 Tetrahydro- and dihydroquinazolinones
08/11/2011US20110195960 Inhibitors of c-fms kinase
08/11/2011US20110195945 Compounds, Compositions and Methods for Treating or Preventing Hypoxic or Ischemic Injury
08/11/2011US20110195904 Methods of treatment using exendin peptides or glp-1 peptides
08/11/2011US20110195893 Use of apolipoproteins to decrease inflammation
08/11/2011US20110195892 Artifical Pulmonary Surfactant Compositions
08/11/2011US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS
08/11/2011US20110195046 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
08/11/2011US20110195042 Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
08/11/2011US20110195032 Menthylcarboxamides and Their Use as Cooling Agents
08/11/2011US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer
08/11/2011US20110195025 Anionic oligosaccharide conjugates
08/11/2011US20110195022 Cd20 antibodies and uses thereof
08/11/2011US20110192396 Pharmaceutical composition for preventing or treating chronic obstructive pulmonary disease
08/11/2011CA2788969A1 Sgc stimulators or sgc activators alone and in combination with pde5 inhbitors for the treatment of cystic fibrosis
08/11/2011CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases